scholarly journals mHealth Real-Time Blood Glucose Monitoring Facilitates Glycemic Management

2016 ◽  
Vol 11 (1) ◽  
pp. 172-173 ◽  
Author(s):  
Michelle F. Magee ◽  
Evgenia Gourgari ◽  
Gretchen A. Youssef ◽  
Carine M. Nassar
Keyword(s):  
Blood Glucose ◽  
Real Time ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Glycemic Management

scholarly journals Prognostic Effect of Glycemic Management In Acute First-Ever Ischemic Stroke On Stroke Recurrence And Mortality For Patients Without Previous Diabetes: A Longitudinal Cohort Study

2021 ◽  
Author(s):  
Hsi- Hsing Yang ◽  
Wu-Chien Chien ◽  
Jen-Jiuan Liaw ◽  
Chia-Chen Yang ◽  
Chi-Hsiang Chung ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Blood Glucose ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Study Endpoint ◽  
Stroke Recurrence ◽  
Research Database ◽  
Cox Regression Analysis ◽  
Glycemic Management

Abstract Objective This study aimed to investigate the short- and long-term prognostic effects of glycemic management on stroke recurrence and mortality in patients with acute first-ever ischemic stroke (FIS) without previous diabetes. Methods In total, 484,952 patients aged ≥20 years with FIS and nonprevious diabetes were retrieved from the 2000 to 2015 Taiwan’s National Health Insurance Research Database. Patients were categorized into the following cohorts: FIS without hyperglycemia (FISw/oHG), FIS with hyperglycemia without glycemic treatment (FISHGw/oGT), and FIS with hyperglycemia with glycemic treatment (FISHGw/GT). The short-term (within 1 year) and long-term (at the endpoint of 9.3 ± 8.6 years) prognostic effects of glycemic treatment and blood glucose monitoring on stroke recurrence and mortality among the cohorts were tested through Cox regression analysis.Results The mortality risk was lower in the FISHGw/GT cohort than in the FISHGw/oGT cohort at 3 months, 6 months, and 1 year (adjusted hazard ratio = 0.68, 0.62, 0.69, respectively, p < 0.001) as well as at the study endpoint, but no difference was observed in stroke recurrence at any time point (p > 0.05). Furthermore, compared with FISHGw/oGT without blood glucose monitoring, FISHGw/GT combined with blood glucose monitoring led to decreased risks of stroke recurrence within 1 year (p < 0.001) and mortality within 1 year and at the study endpoint (p < 0.001). Conclusion For optimal glycemic management in the acute phase and improved prognoses for patients with FIS and nonprevious diabetes with hyperglycemia, intensive blood glucose monitoring combined with glycemic treatment is needed.

Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring (rtCGM) versus Traditional Blood Glucose Monitoring (BG) among US Adults with Type 1 Diabetes

2021 ◽  
pp. 193229682110315
Author(s):  
Benjamin Wong ◽  
Yalin Deng ◽  
Karen L. Rascati
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Adverse Events ◽  
Real Time ◽  
Healthcare Utilization ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Medical Costs ◽  
Blood Glucose Monitoring

Objective: To compare healthcare utilization, costs, and incidence of diabetes-specific adverse events (ie, hyperglycemia, diabetic ketoacidosis, and hypoglycemia) in type 1 diabetes adult patients using real-time continuous glucose monitoring (rtCGM) versus traditional blood glucose monitoring (BG). Methods: Adult patients (≥18 years old) with type 1 diabetes in a large national administrative claims database between 2013 and 2015 were identified. rtCGM patients with 6-month continuous health plan enrollment and ≥1 pharmacy claim for insulin during pre-index and post-index periods were propensity-score matched with BG patients. Healthcare utilization associated with diabetic adverse events were examined. A difference-in-difference (DID) method was used to compare the change in costs between rtCGM and BG cohorts. Results: Six-month medical costs for rtCGM patients ( N = 153) increased from pre- to post-index period, while they decreased for matched BG patients ( N = 153). DID analysis indicated a $2,807 ( P = .062) higher post-index difference in total medical costs for rtCGM patients. Pharmacy costs for both cohorts increased. DID analysis indicated a $1,775 ( P < .001) higher post-index difference in pharmacy costs for rtCGM patients. The incidence of hyperglycemia for both cohorts increased minimally from pre- to post-index period. The incidence of hypoglycemia for rtCGM patients decreased, while it increased marginally for BG patients. Inpatient hospitalizations for rtCGM and BG patients increased and decreased marginally, respectively. Conclusions: rtCGM users had non-significantly higher pre-post differences in medical costs but significantly higher pre-post differences in pharmacy costs (mostly due to the rtCGM costs themselves) compared to BG users. Changes in adverse events were minimal.

IoT Based Non Invasive Glucometer Using Optical Method

2017 ◽  
Vol 7 (9) ◽  
pp. 42
Author(s):  
Saina Sunny ◽  
S. Swapna Kumar
Keyword(s):  
Blood Glucose ◽  
Real Time ◽  
Glucose Monitoring ◽  
Blood Glucose Measurement ◽  
Blood Glucose Monitoring ◽  
World Health ◽  
Glucose Measurement ◽  
Body Parts ◽  
Non Invasive ◽  
The World

Analysis and measurement of Diabetes Mellitus (DM) became one of the critical challenges of the coming future. Since by 2030, diabetes effected are increased to 360 million all over the world by the World Health Organization (WHO) analytical study survey results. The main aim of this paper is non invasive and continuous glucose monitoring with the IoT technology involvement. Traditional finger pricking methods pros and cons are notified and tried to rectify its demerits. The designed device consist of an infrared led having a wavelength of 900 to 1100nm for the optical blood glucose measurement. NIR photodiodes used to collect light collected from body parts and regressive analysis is carried out. The signal processing, data algorithm is based on Beer-Lambert’s law. In assistance with internet of things (IoT) in WiFi range push alerts are reached to the patients and their concerns on real time. Therefore, it helps in emergency, continuous real time blood glucose monitoring. An IOT based noninvasive glucose monitoring will be a milestone for emerging and smart generation.

Development of a biocompatible glucose biosensor for wireless and real time blood glucose monitoring of fish

2012 ◽  
Vol 93 (2) ◽  
pp. 125-139 ◽  
Author(s):  
Mai Takase ◽  
Eiji Takahashi ◽  
Masataka Murata ◽  
Hitoshi Ohnuki ◽  
Kyoko Hibi ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Real Time ◽  
Glucose Monitoring ◽  
Glucose Biosensor ◽  
Blood Glucose Monitoring

Changes in Self-Care Behavior (Summary of Diabetes Self-Care Activities Measure) Using Real-Time Blood Glucose Monitoring with the Free Style Libre

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 902-P
Author(s):  
AYAE KUDARA ◽  
TAKAHIRO TOSAKI ◽  
SHIORI SATO ◽  
AKEMI INAGAKI ◽  
MASAKI KONDO ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Real Time ◽  
Glucose Monitoring ◽  
Self Care ◽  
Blood Glucose Monitoring ◽  
Care Behavior

The advantages of insulin pump therapy and real time glucose monitoring systems as the tools for reducing the frequency of hypoglycemic episodes in the children and adolescents with type 1 diabetes mellitus

2014 ◽  
Vol 60 (2) ◽  
pp. 24-30 ◽  
Author(s):  
D N Laptev
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Type 1 Diabetes Mellitus ◽  
Real Time ◽  
Insulin Pump ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Insulin Pump Therapy ◽  
Pump Therapy

The primary objective of the present study was to analyse the advantages of insulin pump therapy and real time glucose monitoring systems as the tools for reducing the frequency of hypoglycemic episodes. The study included 190 children and adolescents at the age varying from 1 to 18 years suffering from type 1 diabetes mellitus. All the patients were hospitalized at the Endocrinological Research Centre for the treatment the disease using different modalities of insulin therapy, such as multiple injections of insulin (MII) and its continuous subcutaneous infusion (CSII). The blood glucose level was monitored during 72 hours making use of the continuous blind and real time monitoring protocols (blind-CGM and RT-CGM respectively). All the patients were divided into 4 groups depending on the therapeutic modality and the mode of blood glucose monitoring. Group 1 was comprised of the patients given multiple insulin injections in combination with blind glucose monitoring ("blind-CGM + MII"), group 2 included the patients undergoing blind glucose monitoring in conjunction with continuous insulin infusion ("blind-CGM + CSII"), group 3 contained the patients treated by multiple insulin injections followed by real-time blood glucose monitoring ("RT-CGM + MII"), and group 4 was composed of the patients undergoing continuous subcutaneous infusion of insulin combined with real-time blood glucose monitoring ("RT-CGM + CSII"). In all the cases, the blood glucose levels were measured and the occurrence of hypoglycemia during the period of monitoring time was evaluated. It was shown that the highest frequency of hypoglycemia during 72 hours was recorded in the "blind-CGM" group and the lowest one in the RT-CGM groups. Despite adequate self-control, almost half of the patients in the "blind-CGM + MII" group reported at least one hypoglycemic episode either at the daytime or at night ; the duration of such episode was more than 1 hour on the average. In the "blind-CGM" group, CSII resulted in the decrease of the number of hypoglycemic episodes both at night and daytime (p<0.05). In the "RT-CGM + CSII" group, continuous insulin infusion reduced the mean duration of nocturnal hypoglycemic episodes (p<0.05) whereas this parameter was not significantly different between the other groups. It is concluded that hypoglycemia especially nocturnal one is rather a common problem facing children and adolescents suffering from type 1 diabetes mellitus. The use of insulin pump therapy and real time glucose monitoring systems (RT-CGM) makes it possible to substantially decrease the frequency and duration of hypoglycemic episodes in this population group.

Sign in / Sign up

Export Citation Format

Share Document